Skip to main content
. Author manuscript; available in PMC: 2022 Feb 8.
Published in final edited form as: Bone Marrow Transplant. 2016 Sep 12;52(1):20–27. doi: 10.1038/bmt.2016.194

Table 2:

Patient Characteristics (n=102)

Characteristic n (%)
Institution
MDACC 72 (71)
OHSU 21 (21)
NUH 9 (9)

Age
<18 11 (11)
18–39 63 (62)
>40 28 (27)

Sex
Male 77 (75)
Female 25 (25)

Subtype
Early* 28 (27)
Mature 17 (17)
Cortical 27 (26)
ETP 16 (16)
Unknown 14 (14)

WBC × 10 9 /L (Diagnosis)
>100 63 (62)
</=100 18 (18)
Unknown 21 (21)

Extra-Medullary CNS Disease at Diagnosis
Yes 11 (11)
No 90 (88)
Unknown 1 (1)

Extra-Medullary Disease (Any) at Diagnosis
Yes 46 (45)
No 56 (55)

SWOG Cytogenetic Risk at Diagnosis
High/Very High 14 (14)
Intermediate 66 (65)
Unknown 22 (22)

Disease Status at Transplant
CR1 38 (37)
CR2+ 40 (39)
PIF/CR1 6 (6)
No CR 18 (18)

MRD at Transplant (After 2004, n=84)
Yes 18 (21)
No 47 (55)
Unknown 7 (7)
No CR 12 (14)

HCT-CI
0–2 60 (59)
3+ 30 (29)
Unknown 12 (12)

Abbreviations: ETP: Early-Thymic Precursor; WBC: White Blood Cell; CR: Complete Remission; PIF: Primary Induction Failure

*

12 patients had pre-T and 14 patients had pro-T, though there was no statistical difference between the two groups (p=0.571), they were classified together as Early T-ALL.